Photo shows the three-shot recombinant protein COVID-19 vaccine jointly developed by the Institute of Microbiology under the Chinese Academy of Sciences and Anhui Zhifei Longcom Biopharmaceutical Co. Ltd. (Photo provided to Xinhua)